Pharmaceutical

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.

Jul 5, 2025 - 06:00
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.
Read the original article

Tags:

Previous Article

Modella AI and AstraZeneca link for cancer clinical development

Next Article

Big pharma braces for revenue headwinds as patent expiries loom

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BMS and Prime ink potential $3.5bn deal to develop T cell therapies

BMS and Prime ink potential $3.5bn deal to develop T ce...

Oct 2, 2024

STAT+: Bernie Sanders’ accidentally great drug pricing idea

STAT+: Bernie Sanders’ accidentally great drug pricing ...

Mar 28, 2023

Did the government get a bad deal on the Covid-19 boosters?

Did the government get a bad deal on the Covid-19 boost...

Sep 28, 2023